切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2025, Vol. 11 ›› Issue (02) : 135 -141. doi: 10.3877/cma.j.issn.2095-9605.2025.02.008

综述

体重变异性与泛血管疾病关系的研究进展
王国峰, 吕舒, 肖金潭, 刘国力, 刘伯芹()   
  1. 266002 青岛,青岛市市立医院 (青岛市老年病医院)
  • 收稿日期:2024-11-25 出版日期:2025-05-30
  • 通信作者: 刘伯芹

Research progress of the relationship between body weight variability and pan-vascular disease

Guofeng Wang, Shu Lv, Jintan Xiao, Guoli Liu, Boqin Liu()   

  1. Qingdao Municipal Hospital, Qingdao 266002, China
  • Received:2024-11-25 Published:2025-05-30
  • Corresponding author: Boqin Liu
引用本文:

王国峰, 吕舒, 肖金潭, 刘国力, 刘伯芹. 体重变异性与泛血管疾病关系的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(02): 135-141.

Guofeng Wang, Shu Lv, Jintan Xiao, Guoli Liu, Boqin Liu. Research progress of the relationship between body weight variability and pan-vascular disease[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2025, 11(02): 135-141.

随着动脉粥样硬化性心血管疾病日益成为全球主要死亡和致残原因,泛血管疾病已成为一个亟待解决的重大公共卫生问题。系统性防治和针对性干预是泛血管疾病诊疗理念的重点。体重变异性升高是泛血管疾病发生风险和全因死亡的一个重要独立危险因素。体重变异性升高增加心、脑血管事件、糖尿病性血管病变等不良血管事件的发生和发展,并预测患者不良预后。在以患者为中心的综合健康管理中,关注体重健康的同时,还需关注体重控制的长期稳定性,对于进一步降低泛血管疾病的发生、发展有重要意义。

The pan-vascular disease has become a major public health problem that needs to be solved urgently, with the atherosclerotic cardiovascular disease has become a major cause of death and disability worldwide. Systematic prevention and treatment and targeted intervention are the key points in the diagnosis and treatment concept of pan-vascular diseases. High body weight variability is an important risk factor for the risk of pan-vascular disease and all-cause mortality and is independent of baseline weight levels. High body weight variability increases the occurrence and development of adverse vascular events such as cardiac and cerebrovascular events and type diabetic vascular disease, and predicts the poor prognosis of patients. In patient-centered comprehensive health management, it is important to pay attention to the long-term stability of weight control while paying attention to weight, which is of great significance to further reduce the occurrence and development of pan-vascular diseases.

[1]
Wong MJ, Dai YX, Ge JB. Pan-vascular disease: what we have done in the past and what we can do in the future? [J]. Cardiol Plus, 2024, 9(1): 1-5.
[2]
中国医师协会心血管内科医师分会. 泛血管疾病抗栓治疗中国专家共识(2024版) [J]. 中华医学杂志, 2024, 104(12): 906-923.
[3]
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet, 2020, 396(10258): 1223-1249.
[4]
Almuwaqqat Z, Hui Q, Liu C, et al. Long-term body mass index variability and adverse cardiovascular outcomes [J]. JAMA Netw Open. 2024, 7(3): e243062.
[5]
Massey RG, Siddiqui MK, Pearson ER, et al. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis [J]. Cardiovasc Diabetol, 2023, 22(1): 5.
[6]
Mehran L, Honarvar M, Masoumi S, et al. The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts [J]. Front Endocrinol (Lausanne), 2024, 15: 1345781.
[7]
Brownell KD, Greenwood MR, Stellar E, et al. The effects of repeated cycles of weight loss and regain in rats [J]. Physiol Behav, 1986, 38(4): 459-64.
[8]
Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population [J]. N Engl J Med, 1991, 324(26): 1839-1844.
[9]
Ha J, Kwon Y, Kwon YJ, et al. Variability in body weight precedes diagnosis in dementia: A nationwide cohort study [J]. Brain Behav, 2020,10(11): e01811.
[10]
杨雁, 陈颖, 张惠杰, 等. 糖尿病患者体重管理专家共识(2024版) [J]. 中华糖尿病杂志, 2024, 16(9): 959-971.
[11]
Gallo G, Desideri G, Savoia G. Update on obesity and cardiovascular risk: from pathophysiology to clinical management[J]. Nutrients, 2024, 16(16): 2781.
[12]
中华医学会内分泌学分会. 肥胖患者的长期体重管理及药物临床应用指南(2024版) [J]. 中华内分泌代谢杂志, 2024, 40(7): 545-564.
[13]
Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement [J]. Eur Heart J, 2024, 45(38): 4063-4098.
[14]
Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: A report of us and global data from the American Heart Association [J]. Circulation, 2024, 149(8): e347-e913.
[15]
Almuwaqqat Z, Hui Q, Liu C, et al. Long-term body mass index variability and adverse cardiovascular outcomes [J]. JAMA Netw Open, 2024, 7(3): e243062.
[16]
Bangalore S, Fayyad R, Laskey R, et al. Body-weight fluctuations and outcomes in coronary disease [J]. N Engl J Med, 2017, 376(14): 1332-1340.
[17]
Kim DH, Nam GE, Han K, et al. Variabilities in weight and waist circumference and risk of myocardial infarction, stroke, and mortality: A nationwide cohort study [J]. Endocrinol Metab (Seoul), 2020, 35(4): 933-942.
[18]
Nam GE, Kim W, Han K, et al. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: A nationwide cohort study [J]. Diabetes Care, 2020, 43(9): 2234-2241.
[19]
Huang S, Shi K, Ren Y, et al. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis [J]. Cardiovasc Diabetol, 2022, 21(1): 78.
[20]
Kazibwe R, Singleton MJ, Ahmad MI, et al. Association between weight variability, weight change and clinical outcomes in hypertension [J]. Am J Prev Cardiol, 2023, 16: 100610.
[21]
Li Y, Yu Y, Wu Y, et al. Association of body-weight fluctuation with outcomes in heart failure with preserved ejection fraction [J]. Front Cardiovasc Med, 2021, 8: 689591.
[22]
Turicchi J, O'Driscoll R, Horgan, G, et al. Body weight variability is not associated with changes in risk factors for cardiometabolic disease [J]. Int J Cardiol Hypertens, 2020, 6: 100045.
[23]
Sarin HV, Lee JH, Jauhiainen M, et al. Substantial fat mass loss reduces low-grade inflammation and induces positive alteration in cardiometabolic factors in normal-weight individuals [J]. Sci Rep, 2019, 9(1): 3450.
[24]
Manemann SM, Bielinski SJ, Moser ED, et al. Variability in lipid levels and risk for cardiovascular disease: An electronic health record-based population cohort study [J]. J Am Heart Assoc, 2023, 12(5): e027639.
[25]
Goldstein LB. Weighing the effect of overweight/obesity on stroke risk [J]. Stroke, 2024, 55(7): 1866-1868.
[26]
Lu J, Gong S, Zhu J, et al. Relationships between obesity and functional outcome after ischemic stroke: a Mendelian randomization study [J]. Neurol Sci, 2024, 45(8): 3869-3877.
[27]
Kim MK, Han K, Park YM, et al. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population [J]. Circulation, 2018, 138: 2627-2637.
[28]
Ceriello A, Lucisano G, Prattichizzo F, et al. Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register [J]. Cardiovasc Diabetol, 2021; 20(1): 173.
[29]
Bangalore S, Fayyad R, DeMicco DA, et al. Body weight variability and cardiovascular outcomes in patients with type 2 diabetes mellitus [J]. Circ Cardiovasc Qual Outcomes, 2018, 11(11): e004724.
[30]
Bhadada SK, Malhotra B, Shetty AJ. Body Weight Variability and Cardiovascular Health in Diabetes [J]. J Clin Endocrinol Metab, 2023, 108(2): e19-e20.
[31]
Kaze AD, Santhanam P, Erqou S, et al. Body weight variability and risk of cardiovascular outcomes and death in the context of weight loss intervention among patients with type 2 diabete s[J]. JAMA Netw Open, 2022, 5(2): e220055.
[32]
Zonneveld MH, Noordam R, Sabayan B, et al. Weight loss, visit-to-visit body weight variability and cognitive function in older individuals [J]. Age Ageing, 2023, 52(1): afac312.
[33]
Park Y, Kim SH, Ryu J, et al. Association of midlife body-weight variability and cycles with earlier dementia onset: a nationwide cohort study [J]. Alzheimers Res Ther, 2024,16(1): 91.
[34]
Park S, Jeon SM, Jung SY, et al. Effect of late-life weight change on dementia incidence: a 10-year cohort study using claim data in Korea [J]. BMJ Open, 2019, 9(5): e021739.
[35]
Chandrasekaran P, Weiskirchen R. The role of obesity in type 2 diabetes mellitus-an overview [J]. Int J Mol Sci, 2024, 25(3): 1882.
[36]
Prattichizzo F, Veronesi V, Rigoni M, et al. Body weight variability as a predictor of cardiovascular outcomes in type 1 diabetes: A nationwide cohort study [J]. Diabetes Obes Metab, 2024, 12:1-11.
[37]
Mehran L, Mousapour P, Khalili D, et al. BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS) [J]. Sci Rep, 2022, 12(1): 18370.
[38]
Massey RJ, Chen Y, Panova-Noeva M, et al. BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study [J]. Cardiovasc Diabetol, 2024, 23(1): 256.
[39]
Hukportie DN, Li FR, Zhou R, et al. Waist circumference and body mass index variability and incident diabetic microvascular complications: A post hoc analysis of ACCORD trial [J]. Diabetes Metab J, 2022 ,46(5): 767-780.
[40]
方雍乔, 汪文俊, 刘欢欢, 等. 2型糖尿病患者体重变异性与糖尿病肾病发病风险的相关性 [J]. 中华医学杂志, 2024, 104(10): 742-750.
[41]
Nystrom T, Andersson Franko M, Ludvigsson J, et al. Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes [J]. Diabetes Obes Metab, 2024, 26(6): 2509-2512.
[42]
Okada H, Hamaguchi M, Habu M, et al. Association between variability in body mass index and development of type 2 diabetes: Panasonic cohort study [J]. BMJ Open Diabetes Res Care, 2021, 9(1): e002123.
[43]
Sea MM, Fong WP, Huang Y, et al. Weight cycling-induced alteration in fatty acid metabolism [J]. Am J Physiol Regul Integr Comp Physiol, 2000, 279(3): R1145-1155.
[44]
Park MJ, Yoo J, Han K, et al. High body weight variability is associated with increased risk of depression: a nationwide cohort study in South Korea [J]. Psychol Med, 2023, 53(8): 3719-3727.
[45]
Guo TS, Zheng SR, Chen T, et al. The association of long-term trajectories of BMI, its variability, and metabolic syndrome: a 30-year prospective cohort study [J]. E Clinical Medicine, 2024, 69: 102486.
[46]
Yao H, Zhang A, Li D, et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis [J]. BMJ, 2024, 384: e076410.
[47]
颜宥彤, 赵锐, 万谦益, 等. GLP-1受体激动剂——司美格鲁肽的应用及安全性 [J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(2): 88-93.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[3] 陈晓玲, 钟永洌, 刘巧梨, 李娜, 张志奇, 廖威明, 黄桂武. 超高龄髋膝关节术后谵妄及心血管并发症风险预测[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 575-584.
[4] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[5] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[6] 王玲洁, 王瑷萍, 李朝军, 丁跃有, 杨德业, 赵清, 崔兆强, 王京昆, 王宏宇. 心脏和血管健康技术创新研发策略专家共识(2024第一次报告,上海)[J/OL]. 中华临床医师杂志(电子版), 2025, 19(05): 323-336.
[7] 秦楠, 汪川, 穆尼热·穆合塔尔, 蒋升. 2 型糖尿病患者维生素D 与胰岛功能的相关性[J/OL]. 中华临床医师杂志(电子版), 2025, 19(03): 199-205.
[8] 王美琴, 潘海涛, 陈祥菲, 吴婉, 周昱和, 王砚青. S100B 蛋白在心血管疾病中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(03): 229-233.
[9] 张克, 杨占奇, 闫维, 张二明, 向平超. 持续气道正压通气对阻塞性睡眠呼吸暂停综合征患者发生心脑血管事件的影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 433-440.
[10] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[11] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[12] 李振振, 刘震东, 钱昊, 许语阳, 戚悠飞, 肖占祥, 刘敏. 下肢动脉硬化闭塞症与代谢性疾病的相关性研究[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(02): 111-120.
[13] 门航, 厉周, 韩帅. 肥胖与2 型糖尿病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 62-69.
[14] 邓垚, 谢壁成, 吴边, 兰丹凤. 减重手术对肠道菌群及代谢性炎症综合征影响的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 70-75.
[15] 宋宇佳, 孟化. 基于营养刺激激素受体靶点新型减重药物的临床研究现状与进展[J/OL]. 中华肥胖与代谢病电子杂志, 2025, 11(01): 33-39.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?